Interferon Alfa (NAMALWA)
CAS registry number (Chemical Abstracts Service)
Antiviral agent: Treatment of hepatitis
Biological response modifier, BRM
Glycoprotein produced from human lymphoblastoid cells (NAMALWA) induced with Sendai virus
- Interferonum alfa (NAMALWA) (Latin)
- Interferon alfa (NAMALWA) (German)
- Interféron alfa (NAMALWA) (French)
- Interferón alfa (NAMALWA) (Spanish)
- Interferon Alfa (NAMALWA) (OS: JAN)
- Interferon Alfa (NAMALWA) (PH: JP XVI)
Dainippon Sumitomo Pharma, Japan
|JAN||Japanese Accepted Name|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.